The need for better and more affordable healthcare is one of the defining issues of our time.
The system is complex and consists of many parts, ranging from understanding the burden of diseases, doing basic and translational research,testing new therapies, obtaining regulatory approval and providing treatments to patients at sustainable prices.
It’s as much about science as reducing costs and increasing access.
Our purpose is to enable this process. And deliver viable outcomes
TrialValue A.I.+, machine learning enabled predictive analytics kit for clinical research budgeting and benchmarking is launched.
FDA approves new treatment for sickle cell disease. First approval for this rare blood disorder in nearly 20 years